Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes

Laura Roberts, Rachel B. Salit, MD, Lauren Longo, Elisabetta Xue, MD, Corinne Summers, MD, Colleen Delaney, MD MSc, Ann Dahlberg, MD, Filippo Milano, MD PhD

Blood (2019) 134 (Supplement_1): 2048.

https://doi.org/10.1182/blood-2019-126216

Published: 2019

Journal Articles

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial

Filippo Milano, MD PhD, Andrew R Rezvani, MD, Joanne Kurtzberg, MD, Chatchada Karanes, MD, Jonathan A Gutman, MD, Christine Duncan, MD, Alla Keyzner, MD, Rabi Hanna, MD, Tonya Kimberly Marmon, PhD, Ann Dahlberg, MD, Colleen Delaney, MD MSc

Blood (2019) 134 (Supplement_1): 146.

https://doi.org/10.1182/blood-2019-130716

Published: 2019

Journal Articles

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Elisabetta Xue, MD, Hu Xie, Wendy Leisenring, ScD, Louise E Kimball, PhD RN, Sonia Goyal, Lisa Chung, Rachel Blazevic, Byron Maltez, Ann Dahlberg, MD, Rachel B. Salit, MD, Colleen Delaney, MD MSc, Steven A. Pergam, MDMPH, Michael Boeckh, MD, Filippo Milano, MD PhD, Joshua Aiden Hill, MD

Blood (2019) 134 (Supplement_1): 4556.

https://doi.org/10.1182/blood-2019-124211

Published: 2019

Journal Articles

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

Ann Dahlberg, MD, Muna Qayed, MDMSc, Katherine Tarlock, MD, Jessica A. Pollard, MD, Filippo Milano, MD PhD, Soheil Meshinchi, MD PhD, Colleen Delaney, MD MSc

Blood (2019) 134 (Supplement_1): 2614.

https://doi.org/10.1182/blood-2019-130979

Published: 2019

Journal Articles

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Lauren Longo, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Marie Bleakley, MBBS, PhD MMSc, Lauri S Burroughs, MD, Brandon Hadland, MD PhD, Elisabetta Xue, MD, Laura Roberts, Soheil Meshinchi, MD PhD, Kanwaldeep K. Mallhi, MD, Monica Thakar, MD, K Scott Baker, MD MS, Corinne Summers, MD, Ann Dahlberg, MD

Blood (2019) 134 (Supplement_1): 4611.

https://doi.org/10.1182/blood-2019-126062

Published: 2019

Journal Articles

Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells Reduces the Time to Platelet Engraftment and the Number of Platelet and Red Blood Cell Transfusions Required in Patients Receiving Myleloblative Cord Blood Transplants

Emily R Cox, Qian Vicky Wu, Rachel Salit, MD, Colleen Delaney, MD MSc, Filippo Milano, MD PhD

Blood (2016) 128 (22): 1232.

https://doi.org/10.1182/blood.V128.22.1232.1232

Published: 2016

Journal Articles

Multiplexed Engineering of CD19CAR T Cells for Post-Transplant Consolidative Immunotherapy

Corinne Summers, MD, Alexandra Grier, Rebecca Gardner, MD, Colleen Delaney, MD MSc, Michael C Jensen, MD

Blood (2016) 128 (22): 1159.

https://doi.org/10.1182/blood.V128.22.1159.1159

Published: 2016

Journal Articles

Myeloablative Cord Blood Transplantation Yields Excellent Disease Free Survival in Patients with Acute Lymphoblastic Leukemia

David Charles Keahi Oliver, BS, Ryan D Cassaday, MD, Ralph P Ermoian, MD, Ann Dahlberg, MD, Colleen Delaney, MD MSc, Filippo Milano, MD PhD

Blood (2016) 128 (22): 4693.

https://doi.org/10.1182/blood.V128.22.4693.4693

Published: 2016

Journal Articles

Demonstration of Rapid Functional Myeloid Cell Recovery after Infusion of a Universal Donor Ex Vivo Expanded Progenitor Cell Therapy As a Bridging Graft Source

Fabiola V. Merriam, PhD DVM, Suzan Imren, MD, Robert A Landeros, Colleen Delaney, MD MSc

Blood (2016) 128 (22): 3348.

https://doi.org/10.1182/blood.V128.22.3348.3348

Published: 2016

Journal Articles

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Joshua A Hill, MD, Bryan T Mayer, PhD, Hu Xie, MSc, Wendy M Leisenring, PhD, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Meei-Li Huang, PhD, Terry L Stevens-Ayers, MS, Keith R Jerome, MD PhD, Garrett Nichols, MD MS, Danielle M Zerr, MD MPH, Joshua T Schiffer, MD MS, Michael Boeckh, MD

Blood (2015) 126 (23): 3104.

https://doi.org/10.1182/blood.V126.23.3104.3104

Published: 2015

Journal Articles

Distinct Patterns of Early Hematopoietic Reconstitution in Patients Receiving Notch Expanded Non HLA-Matched Off-the-Shelf Cord Blood Derived Hematopoietic Stem and Progenitor Cells

Jianqiang Li, PhD MSc, Allen Jiang, Filippo Milano, MD PhD, Suzan Imren, MD, David Charles Keahi Oliver, BS, Joseph Blake, Colleen Delaney, MD MSc

Blood (2015) 126 (23): 379.

https://doi.org/10.1182/blood.V126.23.379.379

Published: 2015

Journal Articles

Better High Resolution HLA-Matching Is Associated with Lower Transplant Related Mortality after Cord Blood Transplantation

Paige Albert, Colleen Delaney, MD MSc, Rachel Salit, MD, Nancy Anderson, Filippo Milano, MD PhD

Blood (2015) 126 (23): 4405.

https://doi.org/10.1182/blood.V126.23.4405.4405

Published: 2015

Journal Articles

Persistence of the Losing Unit Following Double Umbilical Cord Blood Transplant: Finding the Unseen

David Charles Keahi Oliver, BS, Filippo Milano, MD PhD, Hilary Gammill, MD, Coline Gentil, MS, Sami B. Kanaan, PhD, Judy Allen, MPH, Lee Nelson, MD, Colleen Delaney, MD MSc

Blood (2015) 126 (23): 3109.

https://doi.org/10.1182/blood.V126.23.3109.3109

Published: 2015

Journal Articles

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

Rachel B. Salit, MD, Filippo Milano, MD PhD, Ivy B. Riffkin, David C. Oliver, Nancy L. Anderson, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 3940.

https://doi.org/10.1182/blood.V124.21.3940.3940

Published: 2014

Journal Articles

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant

Corinne Summers, MD, Filippo Milano, MD PhD, Ted A. Gooley, PhD, Ann Dahlberg, MD, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 3860.

https://doi.org/10.1182/blood.V124.21.3860.3860

Published: 2014

Journal Articles

Comorbidity Index in the Context of Cord Blood Transplantation: An Accurate Predictor of Treatment Related Mortality?

David C. Oliver, Filippo Milano, MD PhD, Colleen Delaney, MD MSC, Mohamed L. Sorror, MD MSc, Rachel B. Salit, MD

Blood (2014) 124 (21): 1205.

https://doi.org/10.1182/blood.V124.21.1205.1205

Published: 2014

Journal Articles

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Filippo Milano, MD PhD, Ted A. Gooley, PhD, Brent L. Wood, MD PhD, Ann E Woolfrey, MD, Effie W. Petersdorf, MD, Frederick R. Appelbaum, MD, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 2579.

https://doi.org/10.1182/blood.V124.21.2579.2579

Published: 2014

Journal Articles

Role of Comorbidities in Prognostic Evaluation of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-Mismatched (MM) and Umbilical Cord Blood (UCB) Donor Grafts

Mahmoud Elsawy, MD MSc, Barry E. Storer, PhD, Brenda M. Sandmaier, MD, Colleen Delaney, MD MSC, Frederick R. Appelbaum, MD, Ann E Woolfrey, MD, David G Maloney, MDPhD, Rainer F. Storb, MD, Mohamed L. Sorror, MD MSc

Blood (2014) 124 (21): 2583.

https://doi.org/10.1182/blood.V124.21.2583.2583

Published: 2014

Journal Articles

Lentiviral Transduction Of Notch Ligand Expanded Cord Blood HSC’s To Express a CD19-Specific CAR Generates NK and Myeloid Progeny With Antitumor Activity

Rebecca Gardner, MD, Corinne Summers, MD, Dan Weber, Michael C. Jensen, MD, Colleen Delaney, MD, MSc

Blood (2013) 122 (21): 900.

https://doi.org/10.1182/blood.V122.21.900.900

Published: 2013

Journal Articles

Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Roland B. Walter, MD, PhD, Boglarka Gyurkocza, MD, Barry E. Storer, PhD, John M. Pagel, MD, PhD, Sarah A. Buckley, MD, Mohamed L. Sorror, MD, MSc, Colleen Delaney, MD, MSc, Brent L. Wood, MD, PhD, H. Joachim Deeg, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD

Blood (2013) 122 (21): 1317.

https://doi.org/10.1182/blood.V122.21.1317.1317

Published: 2013

NARROW

Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells Reduces the Time to Platelet Engraftment and the Number of Platelet and Red Blood Cell Transfusions Required in Patients Receiving Myleloblative Cord Blood Transplants

Multiplexed Engineering of CD19CAR T Cells for Post-Transplant Consolidative Immunotherapy

Myeloablative Cord Blood Transplantation Yields Excellent Disease Free Survival in Patients with Acute Lymphoblastic Leukemia

Demonstration of Rapid Functional Myeloid Cell Recovery after Infusion of a Universal Donor Ex Vivo Expanded Progenitor Cell Therapy As a Bridging Graft Source

Detection of Multiple Double-Stranded DNA Viruses after Cord Blood Transplantation Is Frequent and Persistent

Distinct Patterns of Early Hematopoietic Reconstitution in Patients Receiving Notch Expanded Non HLA-Matched Off-the-Shelf Cord Blood Derived Hematopoietic Stem and Progenitor Cells

Better High Resolution HLA-Matching Is Associated with Lower Transplant Related Mortality after Cord Blood Transplantation

Persistence of the Losing Unit Following Double Umbilical Cord Blood Transplant: Finding the Unseen

Second Allogeneic Transplant with Cord Blood for Treatment of Failed First Allogeneic Transplant Due to Primary Graft Failure or Disease Recurrence

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant

Comorbidity Index in the Context of Cord Blood Transplantation: An Accurate Predictor of Treatment Related Mortality?

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Role of Comorbidities in Prognostic Evaluation of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-Mismatched (MM) and Umbilical Cord Blood (UCB) Donor Grafts

Lentiviral Transduction Of Notch Ligand Expanded Cord Blood HSC’s To Express a CD19-Specific CAR Generates NK and Myeloid Progeny With Antitumor Activity

Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only